Attribute | HCV | HBV | HCV/HBV | HCV/HIV | HBV/HIV | HBV/HCV/HIV |
---|---|---|---|---|---|---|
Cohort size | 82 601 | 42 694 | 3179 | 683 | 277 | 38 |
Age [years] at entry into study†median (IQR) | 37 (29-44) | 35 (27-44) | 35 (29-43) | 36 (30-41) | 37 (30-44) | 35 (29-42) |
Males N (%) | 52 016 (63) | 23 105 (54) | 2314 (73) | 622 (91) | 263 (95) | 35 (92) |
Diagnosed with HCV/HBV during study period N (%)†| 31 221 (38) | 17 054 (40) | 1479 (47) | 272 (40) | 93 (34) | 24 (37) |
Hospitalized during study period N (%)†,‡ | 33 152 (40) | 12 381 (29) | 1524 (48) | 371 (54) | 146 (53) | 24 (63) |
Died during study period N (%)†| 2844 (3) | 755 (2) | 156 (5) | 73 (11) | 33 (12) | 9 (24) |
Total person years f/up†| 404 471 | 206 943 | 15 023 | 3115 | 1278 | 152 |
Mean person years f/up per person†| 4.9 | 4.8 | 4.7 | 4.6 | 4.6 | 4.0 |